Clinical trial
The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)
NCT04329923 is registered in ClinicalTrials.gov with Ravi Amaravadi, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine)
- Lead sponsor
- Ravi Amaravadi, MD
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 9, 2020
- Completion date
- November 13, 2020
- Enrollment
- 173 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.